STOCKHOLDERS DEFICIT |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| STOCKHOLDERS DEFICIT | |
| STOCKHOLDERS' DEFICIT | NOTE 5 – STOCKHOLDERS’ DEFICIT
Preferred Stock
The authorized preferred stock consists of 10,000,000 shares with a par value $0.001 per share. The board of directors has broad discretion in setting the rights, preferences and privileges of one or more series of preferred stock.
On September 3, 2016, the Company issued 51 Series A preferred shares to the Chief Executive Officer. The Series A preferred shares have voting rights, resulting in the Series A stockholder holding in aggregate approximately 51% of the total voting power of all issued and outstanding voting capital of the Company.
Common Stock
The Company has authorized 20,000,000 shares with a par value $0.001 per share.
Year ended December 31, 2025
During the year ended December 31, 2025, the Company issued 69,166 shares of common stock for the exercise of 103,750 units of share purchase warrants valued at $118,722.
During the year ended December 31, 2025, the Company issued 36,000 shares of common stock valued at $47,000 to consultants for service rendered.
Year ended December 31, 2024
During the year ended December 31, 2024, the Company issued 15,792 shares of common stock for the exercise of 20,441 units of share purchase warrants valued at $45,984.
During the year ended December 31, 2024, the Company issued an aggregate of 35,000 shares of common stock to the consultants of the Company for service rendered valued at $70,000.
During the year ended December 31, 2024, the Company issued 10,000 shares of common stock to the Director of the Company for service rendered valued at $20,000.
As of December 31, 2025 and December 31, 2024, the issued and outstanding common stock was 555,651 shares and 450,485 shares, respectively. |